Unpacking the Decline: Why was Starlix discontinued?
•
4 min read
In 2023, the brand-name diabetes medication Starlix (nateglinide) was officially discontinued in the U.S., following a similar withdrawal from the European market years prior. The definitive reason why was Starlix discontinued, according to its manufacturer, was based on commercial viability and diminishing market demand, not safety issues.